Sulfated chitosan rescues dysfunctional macrophages and accelerates wound healing in diabetic mice

Tong Shen,Kai Dai,Yuanman Yu,Jing Wang,Changsheng Liu
DOI: https://doi.org/10.1016/j.actbio.2020.09.035
IF: 10.633
2020-11-01
Acta Biomaterialia
Abstract:<p>Emerging evidence suggests that dysfunctional macrophages can cause chronic inflammation and impair tissue regeneration in diabetic wounds. Therefore, improving macrophage behaviors and functions may improve therapeutic outcomes of current treatments in diabetic wounds. Herein, we present a sulfated chitosan (SCS)-doped Collagen type I (Col I/SCS) hydrogel as a candidate for diabetic wound treatments, and assess its efficacy using streptozocin (STZ)-induced diabetic wound model. Results showed that Col I/SCS hydrogel significantly improved wound closure rate, collagen deposition, and revascularization in diabetic wounds. Flow cytometry analysis and immunofluorescent staining analysis showed that the Col I/SCS hydrogel accelerated the resolution of excessive inflammation by reducing the polarization of M1-like macrophages in chronic diabetic wounds. In addition, ELISA analysis revealed that the Col I/SCS hydrogel reduced the production of pro-inflammatory interleukin (IL)-6 and increased the production of anti-inflammatory cytokines including IL-4 and transforming growth factor-beta 1 (TGF-β1) during wound healing. Moreover, the Col I/SCS hydrogel enhanced the transdifferentiation of macrophages into fibroblasts, which enhanced the formation of collagen and the extracellular matrix (ECM) in wound tissue. We highlight a potential application of manipulating macrophages behaviors in the pathological microenvironment via materials strategy.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
This paper attempts to solve several key problems in the process of diabetic wound healing: 1. **Chronic Inflammatory Response**: There is a persistent inflammatory response during the healing process of diabetic wounds, which hinders the normal healing process. Chronic inflammation leads to the infiltration of a large number of inflammatory cells (such as neutrophils and macrophages). In particular, the function of macrophages in wound healing is impaired, and they cannot effectively convert their phenotypes from the pro - inflammatory M1 type to the anti - inflammatory M2 type, resulting in the persistence of inflammation. 2. **Reduced Angiogenesis**: The formation of new blood vessels during the healing process of diabetic wounds is reduced, further affecting the wound repair ability. 3. **Macrophage Dysfunction**: The abnormal function of macrophages in diabetic wounds results in their inability to effectively remove pathogens and tissue debris, and at the same time reduces the secretion of anti - inflammatory cytokines and growth factors, affecting the normal healing of wounds. 4. **Limited Collagen Deposition and Skin Stiffness**: Due to the inhibition of the trans - differentiation of macrophages into fibroblasts, the collagen deposition and skin stiffness in diabetic wounds are limited, affecting the final repair quality of wounds. To solve the above problems, the author designed a hydrogel (Col I/SCS) based on type I collagen and sulfated chitosan (SCS), aiming to accelerate the wound healing of diabetic mice by regulating the behavior and function of macrophages. Specifically, this study hopes to improve wound healing through the following ways: - **Reduce the Proportion of M1 - type Macrophages**: By reducing the proportion of pro - inflammatory M1 - type macrophages, the chronic inflammatory response is alleviated. - **Increase the Proportion of M2 - type Macrophages**: By increasing the proportion of anti - inflammatory M2 - type macrophages, wound healing is promoted. - **Promote the Trans - Differentiation of Macrophages into Fibroblasts**: Enhance the formation of collagen and extracellular matrix (ECM) and improve the quality of wound healing. - **Promote Angiogenesis**: By increasing the secretion of growth factors such as vascular endothelial growth factor (VEGF), promote the formation of new blood vessels. Through these mechanisms, the Col I/SCS hydrogel can significantly improve the wound healing speed and quality of diabetic mice.